Quick Answer
Vir Biotechnology, Inc. reported Operating Income of -$479.33 million for fiscal year 2025.
Vir Biotechnology, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$479.33M | +18.4% |
| 2024 | -$587.16M | +14.2% |
| 2023 | -$684.30M | -182.1% |
| 2022 | $833.07M | +98.0% |
| 2021 | $420.75M | +241.7% |
| 2020 | -$296.98M | -66.9% |
| 2019 | -$177.98M | -50.0% |
| 2018 | -$118.69M | -45.6% |
| 2017 | -$81.50M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$173.44M | +25.0% | -46.5% |
| June 30, 2025 | -$118.42M | +25.4% | +15.1% |
| March 31, 2025 | -$139.55M | -74.3% | +39.7% |
| September 30, 2024 | -$231.30M | -23.9% | -45.8% |
| June 30, 2024 | -$158.63M | +26.3% | -98.1% |
| March 31, 2024 | -$80.08M | +44.1% | +57.1% |
| September 30, 2023 | -$186.73M | -195.8% | +13.2% |
| June 30, 2023 | -$215.19M | +4.5% | -50.1% |
- Vir Biotechnology, Inc. showed an increase of +18.4% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Vir Biotechnology, Inc.’s operating income has declined by 488.2% (from -$81.50 million to -$479.33 million).
- The most recent figure is from Vir Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: